Levamisole in childhood idiopathic nephrotic syndrome: new promises, and advocacy for global access-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Levamisole in childhood idiopathic nephrotic syndrome: new promises, and advocacy for global access

Published:2024-05 Issue:5 Volume:105 Page:932-934
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Chan Eugene Yu-hin^ORCID,Boyer Olivia^ORCID

Publisher

Elsevier BV

Reference9 articles.

1. Childhood nephrotic syndrome;Vivarelli;Lancet,2023

2. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome;Trautmann;Pediatr Nephrol,2022

3. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome;Gruppen;Kidney Int,2018

4. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial;Sinha;Kidney Int,2019

5. An open label non-inferiority randomized controlled trial evaluated alernate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome;Sinha;Kidney Int,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP